Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00984074 · ClinicalTrials.gov registry record

MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer

A clinical trial of Head and Neck Cancer, sponsored by Abramson Cancer Center at Penn Medicine.

Completed
Registry status
3
Enrollment target
1
Study location

NCT00984074: Completed study of Head and Neck Cancer, sponsored by Abramson Cancer Center at Penn Medicine.

NCT00984074 is a study of Head and Neck Cancer that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 3 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00984074, a study of Head and Neck Cancer, has completed, sponsored by Abramson Cancer Center at Penn Medicine.

COMPLETED
Registry status
3 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: Diagnostic procedures, such as specialized types of magnetic resonance imaging (MRI), may help in planning radiation therapy that does less damage to normal tissues. PURPOSE: This phase I trial is studying using functional MRI to see how well it works in planning radiation therapy in patients undergoing radiation therapy to the base of the skull and/or brain for nonmetastatic head and neck cancer.

Conditions Studied

Head and Neck Cancer

Interventions

  • RADIATION intensity-modulated radiation therapy
  • PROCEDURE dynamic contrast-enhanced magnetic resonance imaging
  • PROCEDURE blood-oxygen-level-dependent functional magnetic resonance imaging
  • PROCEDURE diffusion tensor imaging
  • PROCEDURE functional magnetic resonance imaging

Study Locations (1)

Pennsylvania

  • Abramson Cancer Center of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2008-10
Est. Completion 2011-12
Abramson Cancer Center at Penn Medicine

402 total trials

What the finished NCT00984074 record still lists

NCT00984074 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 5 interventions - of which intensity-modulated radiation therapy is the first listed.

NCT00984074 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00984074 about?

NCT00984074 is a clinical study titled "MRI Mapping in Planning Radiation Therapy to the Base of Skull and Brain in Patients With Nonmetastatic Head and Neck Cancer". RATIONALE: Diagnostic procedures, such as specialized types of magnetic resonance imaging (MRI), may help in planning radiation therapy that does less damage to normal tissues. PURPOSE: This phase I trial is studying using functional MRI to see how well it works in planning radiation therapy in pat...

What is the current status of trial NCT00984074?

This trial is currently completed. The enrollment target is 3 participants. The study started on 2008-10. Estimated completion is 2011-12.

What conditions does trial NCT00984074 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT00984074?

The interventions under investigation include: intensity-modulated radiation therapy (RADIATION), dynamic contrast-enhanced magnetic resonance imaging (PROCEDURE), blood-oxygen-level-dependent functional magnetic resonance imaging (PROCEDURE), diffusion tensor imaging (PROCEDURE), functional magnetic resonance imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00984074?

This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00984074 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00984074's enrollment target sits among peer trials

3 247th of 250 higher than 2 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00984074, the US trial registry maintained by the National Library of Medicine. NCT00984074 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.